Home

Elevance Health, Inc. Common Stock (ELV)

285.72
-3.38 (-1.17%)
NYSE · Last Trade: Jul 28th, 12:21 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close289.10
Open288.78
Bid285.71
Ask285.83
Day's Range283.87 - 291.50
52 Week Range274.40 - 567.26
Volume671,516
Market Cap66.48B
PE Ratio (TTM)12.13
EPS (TTM)23.6
Dividend & Yield6.840 (2.39%)
1 Month Average Volume3,101,126

Chart

News & Press Releases

Centene's First Quarterly Loss In 13 Years Sends Shares Crashingbenzinga.com
Centene reported a Q2 loss and pulled its 2025 guidance despite rising revenue, citing higher healthcare costs and shifting risk adjustment estimates.
Via Benzinga · July 25, 2025
Centene, Cigna, Others Drop As Molina's Results Rattle Sectorbenzinga.com
Molina Healthcare missed Q2 EPS estimates and lowered its 2025 guidance, pressuring major health insurers including UnitedHealth and Centene.
Via Benzinga · July 24, 2025
Elevance Health, EchoStar, Icahn Enterprises, Evolent Health, and The Trade Desk Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after a new trade agreement between the United States and Japan spurred a broad market rally. 
Via StockStory · July 23, 2025
History of Oscar Health, Inc.: Revolutionizing Health Insurance with Technology – Stock and Share Overview (NYSE:OSCR)
Oscar Health, Inc. (NYSE:OSCR) stands as a disruptive force in the American health insurance landscape, emerging as a pioneer at the crossroads of technology and healthcare. Since its inception in 2012, Oscar Health has sought to simplify, personalize, and digitize the insurance experience, aiming to reshape a sector often
Via MarketMinute · July 23, 2025
States Sue to Block HHS Rule Cutting Health Coverage; ICE Use of Medicaid Data Sparks Outcrystocktwits.com
Via Stocktwits · July 17, 2025
Study Finds Digital Asthma Program Significantly Improves Symptom Control in Adults
A groundbreaking clinical trial led by multidisciplinary researchers found that a digital asthma self-management (DASM) program significantly improved asthma symptom control in adults, with benefits sustained over 12 months. Program participants used everyday devices - like Apple Watch and iPhone – along with a tailored mobile app to help them manage their asthma. The findings represent some of the most compelling evidence to date supporting the use of digital health technologies in asthma care.
By Elevance Health, Inc. · Via Business Wire · July 22, 2025
UnitedHealth Is Approaching a Pivotal Moment. Should Investors Buy the Stock Before July 29?fool.com
Via The Motley Fool · July 22, 2025
1 Oversold Stock Set for a Comeback and 2 We Ignore
Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds.
Via StockStory · July 22, 2025
Schlumberger, Stellantis And ASML Holding Are Among Top 10 Large Cap Losers Last Week (July 14-July 18): Are The Others In Your Portfolio?benzinga.com
Elevance Health and Waters led the weekly large-cap losers, hit by weak earnings, lowered guidance, and analyst downgrades.
Via Benzinga · July 20, 2025
QuidelOrtho, Acadia Healthcare, Elevance Health, Molina Healthcare, and Alignment Healthcare Stocks Trade Down, What You Need To Know
A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like Elevance Health and Humana seeing declines due to an analyst downgrade and a lost lawsuit regarding Medicare bonus payments, respectively. 
Via StockStory · July 18, 2025
What's going on in today's session: S&P500 moverschartmill.com
Stay updated with the movements of the S&P500 index one hour before the close of the markets on Friday. Discover which stocks are leading as top gainers and losers in today's session.
Via Chartmill · July 18, 2025
Invesco, Vistra, Dell, Coinbase Trend In Midday Trade: S&P 500 Hits Record Highstocktwits.com
Via Stocktwits · July 18, 2025
These S&P500 stocks have an unusual volume in today's sessionchartmill.com
Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Friday. Stay informed about the market activity below.
Via Chartmill · July 18, 2025
Top S&P500 movers in Friday's sessionchartmill.com
Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top S&P500 gainers and losers in today's session.
Via Chartmill · July 18, 2025
What's going on in today's session: S&P500 gap up and gap down stockschartmill.com
Stay updated with the S&P500 gap up and gap down stocks on Friday. Get a glimpse of the market's movement during today's session.
Via Chartmill · July 18, 2025
This Elevance Health Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Fridaybenzinga.com
Via Benzinga · July 18, 2025
Top S&P500 movers in Thursday's sessionchartmill.com
Curious about the top performers within the S&P500 index one hour before the close of the markets on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Via Chartmill · July 17, 2025
Unusual volume S&P500 stocks in Thursday's sessionchartmill.com
Let's have a look at the S&P500 stocks with an unusual volume in today's session.
Via Chartmill · July 17, 2025
Nasdaq 100 Sets New Records, Small Caps Outperform: What's Moving Markets Thursday?benzinga.com
U.S. equities climbed on Thursday, with the S&P 500 briefly testing a record high 6,300 level at midday in New York, bolstered by strong earnings and upbeat retail sales data that reinforced investor risk appetite.
Via Benzinga · July 17, 2025
Stay informed with the top movers within the S&P500 index on Thursday.chartmill.com
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Thursday as we examine the latest happenings in today's session.
Via Chartmill · July 17, 2025
Which S&P500 stocks are gapping on Thursday?chartmill.com
Thursday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.
Via Chartmill · July 17, 2025
Elevance Health Hit By Medicaid Troubles, Trims Outlookbenzinga.com
Elevance Health topped Q2 revenue estimates but missed on EPS and cut its 2025 guidance due to rising medical cost trends in Medicaid and ACA.
Via Benzinga · July 17, 2025
Elevance Health Stock Slips Pre-Market After Slashing Full-Year Earnings Guidance: Retail Now Eyes UnitedHealth Q2 Resultsstocktwits.com
The health insurer now expects its adjusted net income per diluted share to be approximately $30.00, down from its previous guidance of $34.15 to $34.85.
Via Stocktwits · July 17, 2025
Elevance Health (NYSE:ELV) Beats Q2 Sales Targets
Health insurance provider Elevance Health (NYSE:EVH) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 13.4% year on year to $49.78 billion. Its non-GAAP profit of $8.84 per share was 1.4% below analysts’ consensus estimates.
Via StockStory · July 17, 2025
Elevance Health Reports Second Quarter 2025 Results
Elevance Health, Inc. (NYSE: ELV) reported second quarter 2025 results.
By Elevance Health, Inc. · Via Business Wire · July 17, 2025